Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 1,559 shares at $13.33 ($21K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
Scheduled sale ($21k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |